Table 2 Comparison of corrected Ca, P, and iPTH achievement rates with DOPPS5.
From: The current status of chronic kidney disease-mineral and bone disorder management in China
Sichuan (n = 7053) | China-DOPPS5 (n = 1186) | Europe (n = 3651) | North america (n = 13,080) | P | |
|---|---|---|---|---|---|
Corrected Ca, n | 5583 | 1186 | 3651 | 13,080 | |
Corrected Ca (mmol/L), % | |||||
< 2.1 | 31.3abc | 25 | 20 | 12 | < 0.001 |
2.1–2.5 | 57.6abc | 62 | 72 | 77 | < 0.001 |
> 2.5 | 11.1b | 13 | 8 | 11 | < 0.001 |
P, n | 6413 | 1186 | 3651 | 13,080 | |
P (mmol/L), % | |||||
< 1.13 | 10.9ab | 7 | 17 | 12 | < 0.001 |
1.13–1.78 | 39.7bc | 39 | 54 | 56 | < 0.001 |
> 1.78 | 49.4abc | 55 | 29 | 33 | < 0.001 |
iPTH, n | 5610 | 1186 | 3651 | 13,080 | |
iPTH (pg/mL), % | |||||
< 150 | 21.3abc | 27 | 30 | 18 | < 0.001 |
150–600 | 55.0c | 52 | 57 | 64 | < 0.001 |
> 600 | 24.1bc | 21 | 14 | 18 | < 0.001 |
